Retained Earnings (Accumulated Deficit) of Achilles Therapeutics plc from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Achilles Therapeutics plc quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2020 to 30 Jun 2024.
  • Achilles Therapeutics plc Retained Earnings (Accumulated Deficit) for the quarter ending 30 Jun 2024 was $288,606,000, a 28% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $288,606,000 -$63,967,000 -28% 30 Jun 2024 6-K 14 Aug 2024 2024 Q2
Q4 2023 $259,952,000 -$69,665,000 -37% 31 Dec 2023 6-K 14 Aug 2024 2024 Q2
Q2 2023 $224,639,000 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $190,287,000 -$71,176,000 -60% 31 Dec 2022 20-F 04 Apr 2024 2023 FY
Q4 2021 $119,111,000 -$61,099,000 -105% 31 Dec 2021 20-F 07 Mar 2023 2022 FY
Q4 2020 $58,012,000 31 Dec 2020 20-F 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.